HPMC Capsule Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (With Gelling Aid, Without Gelling Aid); Route of Administration (Oral, Inhalation, Vaginal, Rectal); End User (Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies, Cosmetic Companies); and Geography
Report Code: TIPRE00021172
| No. of Pages: 150
| Category: Medical Device
| Status: Upcoming
Hydroxypropyl methylcellulose (HPMC), also known as hypromellose, is a synthetically modified version of the natural polymer cellulose that is safe for human consumption. Because HPMC capsules are made from plant extracts, they are quickly becoming a popular alternative to hard shell gelatin capsules. They provide excellent alternatives to gelatin capsules, meeting the dietary and cultural needs of vegetarians. Due to their thermal reversible gelation property, the HPMC material is present in the form of an off-white powder or granules that are hygroscopic and practically insoluble in hot water, acetone, and chloroform, but disintegrate readily in cold water, forming a colloidal solution. The FDA conducted clinical trials on the safety of HPMC material in rats and found no adverse reactions. As a result, it is considered safe for human consumption. In-vitro studies have also shown that the capsules perform better than gelatin capsules in terms of dissolution/disintegration and development time.
The drawbacks of gelatin capsules such as water content, along with the significant acceptance of as well as demand from vegetarians for alternatives will spur the demand for HPMC capsule. Additionally, changing government regulations & guidelines for the human consumption of HPMC capsules, and adoption of better health care facilities expected to boost the market growth to significant extent over the forecast period. However, stringent regulations related to hydroxypropyl methylcellulose in pharmaceutical industry coupled with threat from various substitutes are some the major factor which may restraint the growth of the market in the forecasted period.
The "Global HPMC Capsule Market Analysis to 2028" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of HPMC capsule market with detailed market segmentation by equipment, software, services, indication, and geography. The global HPMC capsule market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading HPMC capsule market players and offers key trends and opportunities in the market.
The global HPMC capsule market is segmented into product, route of administration, and end-user. Based on the product, the HPMC capsule market is segmented into with gelling aid & without gelling aid. Based on the route of administration, the HPMC capsule market is segmented into oral, inhalation and vaginal. Based on the end-user, the HPMC capsule market is segmented into pharmaceutical companies, CMOS, food & beverage and cosmetics companies.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global HPMC capsule market based on various segments. It also provides market size and forecast estimates from year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The HPMC capsule market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting HPMC capsule market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the HPMC capsule market in these regions.
Get more information on this report :
The reports cover key developments in the HPMC capsule market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from HPMC capsule market are anticipated to lucrative growth opportunities in the future with the rising demand for HPMC capsule in the global market. Below mentioned is the list of few companies engaged in the HPMC capsule market.
The report also includes the profiles of key HPMC capsule market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Qualicaps Co., Ltd.
Suheung Capsule Co. Ltd.
SUNIL HEALTHCARE LIMITED
Mitsubishi Chemical Holdings Corporation
BioCaps Enterprise, Inc.
HealthCaps India Ltd
Baotou Capstech Co., Ltd
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.